Joan Walker to Metformin
This is a "connection" page, showing publications Joan Walker has written about Metformin.
Connection Strength
0.059
-
A randomized phase II/III study of paclitaxel/carboplatin/metformin versus paclitaxel/carboplatin/placebo as initial therapy for measurable stage III or IVA, stage IVB, or recurrent endometrial cancer: An NRG oncology/GOG study. Gynecol Oncol. 2025 Apr; 195:66-74.
Score: 0.059